Provided by Tiger Trade Technology Pte. Ltd.

Eaton Vance Tax-Managed Buy-Write Opportunities Fund

14.56
+0.05000.34%
Volume:102.48K
Turnover:1.49M
Market Cap:1.70B
PE:4.98
High:14.62
Open:14.52
Low:14.50
Close:14.51
52wk High:14.83
52wk Low:10.64
Shares:116.75M
Float Shares:116.60M
Volume Ratio:1.95
T/O Rate:0.09%
Dividend:1.19
Dividend Rate:8.18%
EPS(TTM):2.92
EPS(LYR):2.92
ROE:9.94%
ROA:0.10%
PB:1.00
PE(LYR):4.98

Loading ...

Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™

GlobeNewswire
·
Feb 06

Press Release: Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

Dow Jones
·
Feb 03

Denali Therapeutics To Host Webcast Highlighting Presentations on Enzyme TransportVehicle™ Programs at the 2026 WORLDSymposium™

GlobeNewswire
·
Feb 02

Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome

GlobeNewswire
·
Jan 06

Press Release: Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

Dow Jones
·
Dec 31, 2025

Press Release: Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

Dow Jones
·
Dec 02, 2025

Press Release: Denali Therapeutics Announces Board and Executive Leadership Updates

Dow Jones
·
Nov 07, 2025

Press Release: Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

Dow Jones
·
Nov 04, 2025

Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184

GlobeNewswire
·
Oct 16, 2025

Press Release: Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

Dow Jones
·
Oct 01, 2025

Press Release: Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

Dow Jones
·
Sep 03, 2025

Press Release: Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

Dow Jones
·
Aug 30, 2025

Scott E. Wennerholm Appointed as Chairperson of Eaton Vance Tax-Managed Buy-Write Opportunities Fund Board

Reuters
·
Aug 29, 2025

Eaton Vance Fund Appoints Susan J. Sutherland as Acting Chairperson Following Passing of Mark R. Fetting; Board Size Reduced

Reuters
·
Aug 15, 2025

Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection

GlobeNewswire
·
Aug 13, 2025